Edition:
United States

Nestle SA (NESN.F)

NESN.F on Frankfurt Stock Exchange

72.77EUR
10:57am EST
Change (% chg)

€-0.43 (-0.59%)
Prev Close
€73.21
Open
€73.35
Day's High
€73.35
Day's Low
€72.67
Volume
10,768
Avg. Vol
35,563
52-wk High
€79.13
52-wk Low
€65.40

Chart for

About

Nestle S.A. is a nutrition, health and wellness company. The Company's segments are Zone Europe, Middle East and North Africa (EMENA); Zone Americas (AMS); Zone Asia, Oceania and sub-Saharan Africa (AOA); Nestle Waters; Nestle Nutrition, and Other Businesses. The Company operates in the United States, Greater China Region,... (more)
No analyst recommendations are available for .

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 21.88 15.67
EPS (TTM): -- -- --
ROI: -- 12.50 34.62
ROE: -- 15.68 16.00

Nestle to buy vitamin maker Atrium Innovations for $2.3 billion

LONDON Nestle is buying Canadian vitamin maker Atrium Innovations for $2.3 billion, expanding its presence in consumer healthcare as it seeks to offset weakness in packaged foods.

Dec 05 2017

UPDATE 3-Nestle to buy vitamin maker Atrium Innovations for $2.3 bln

* Company focused on US market, scope for expansion elsewhere (Adds comments)

Dec 05 2017

BRIEF-Nestle exec says Atrium will add to earnings immediately

* NESTLE EXEC SAYS ATRIUM INNOVATION ACQUISITION WILL ADD TO EARNINGS

Dec 05 2017

Nestle to buy vitamin maker Atrium Innovations for $2.3 billion

LONDON, Dec 5 Nestle is paying $2.3 billion to buy Canadian vitamin maker Atrium Innovations, it said on Tuesday, expanding its presence in the consumer healthcare market as it seeks to offset weakness in its traditional packaged foods.

Dec 05 2017

BRIEF-Nestle close to buying Atrium Innovations for about $2.3 bln - WSJ

* NESTLE CLOSE TO BUYING ATRIUM INNOVATIONS FOR ABOUT $2.3 BILLION - WSJ Source text - http://on.wsj.com/2BBlJpi Further company coverage:

Dec 05 2017

Swiss stocks - Factors to watch on Dec 4

ZURICH, Dec 4 The Swiss blue-chip SMI was seen opening 1 percent higher at 9,365 points on Monday, according to premarket indications by bank Julius Baer .

Dec 04 2017

German stocks - Factors to watch on December 4

FRANKFURT, Dec 4 The following are some of the factors that may move German stocks on Monday:

Dec 04 2017

Deals of the day-Mergers and acquisitions

Dec 1 The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Friday:

Dec 01 2017

Nestle, Stada prepare rival bids for Germany's Merck consumer health: sources

LONDON/FRANKFURT Swiss food giant Nestle and the private equity owners of German drug firm Stada are both preparing tentative bids for Merck KgaA's consumer health unit, several sources told Reuters.

Dec 01 2017

Nestle, Stada prepare rival bids for Germany's Merck consumer health - sources

LONDON/FRANKFURT, Nov 30 Swiss food giant Nestle and the private equity owners of German drug firm Stada are both preparing tentative bids for Merck KgaA's consumer health unit, several sources told Reuters.

Dec 01 2017

Earnings vs. Estimates